Announcements Trials
Browse Landscape

Phase

Phase 2 1Phase 1 1

Status

Terminated 2Completed 2Not yet recruiting 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Other hematologic neoplasm 28Myeloid 9Dermatologic 8Plasma cell 3Genitourinary 3Thoracic 2Lymphoid 2Gynecologic 2Classical hematology 2CNS 2Tumor-Agnostic 1Other neoplasm 1

Conditions

Lymphoma, T-Cell, Cutaneous 2Multiple Myeloma 1Lymphoma 1

Interventions

Rituximab 702Cyclophosphamide 645Vincristine 353Doxorubicin 309Etoposide 305Cytarabine 271Filgrastim 250Prednisone 249Methotrexate 241fludarabine phosphate 231Dexamethasone 209fludarabine 184Peripheral Blood Stem Cell Transplantation 166Radiotherapy 161Granulocyte Colony-Stimulating Factor 145Lenalidomide 144Bendamustine Hydrochloride 142Bortezomib 127Melphalan 126ibrutinib 111Busulfan 111Mycophenolic Acid 108Whole-Body Irradiation 107Tacrolimus 96Cyclosporine 87Gemcitabine 82Ifosfamide 80Calcium Dobesilate 80Alemtuzumab 80Leucovorin 78

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Completed × Tretinoin × Lymphoid × Clear all
NCT00002479 2012-05-30

Tretinoin in Treating Patients With Mycosis Fungoides or Sezary Syndrome

Northwestern University

Phase 2 Completed
DermatologicLymphoid

Lymphoma, Lymphoma, T-Cell, Cutaneous

NCT00400556 2006-11-17

ATRA Plus G-CSF for Mobilization of Hematopoietic Stem and Progenitor Cells

Peter MacCallum Cancer Centre, Australia

Phase 1 Completed
6 enrolled
DermatologicLymphoidPlasma cell

Multiple Myeloma, Lymphoma, T-Cell, Cutaneous

Data powered by HemOnc (CC BY 4.0) Colophon âš¡